Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
Boditech AFIAS Total Anti-Infliximab Boditech AFIAS Total Anti-Infliximab Boditech AFIAS Total Anti-Infliximab
Boditech AFIAS Total Anti-Infliximab
Boditech AFIAS Total Anti-Infliximab Boditech AFIAS Total Anti-Infliximab

Boditech AFIAS Total Anti-Infliximab

Product Details:

  • Usage Type Clinical Diagnostics
  • Features Rapid, Reliable, Easy to Use, High Sensitivity
  • Measurement Range 1.0100.0 AU/mL
  • Display Type External Analyzer
  • Accuracy High (CV <10%)
  • Instruments Type Immunofluorescence Cartridge
  • Shelf Life 12 Months
  • Click to View more
X

Boditech AFIAS Total Anti-Infliximab Price And Quantity

Boditech AFIAS Total Anti-Infliximab Product Specifications

  • Yes
  • Dependent on Analyzer (Typically < 50 W)
  • Clinical Diagnostics
  • Rapid, Reliable, Easy to Use, High Sensitivity
  • Analyzer Dependent
  • Immunofluorescence Cartridge
  • 12 Months
  • Single Use
  • Silent Operation
  • White / Blue
  • 1.0100.0 AU/mL
  • External Analyzer
  • High (CV <10%)
  • No
  • Medical Grade Plastic & Reagents
  • Immunoassay Analyzer Test Kit
  • New
  • 28C (Refrigerated)
  • External Analyzer Device
  • Yes
  • Automatic
  • Cartridge: ~60 x 20 x 10 mm (Approx.)
  • Lightweight, <100g per cartridge
  • Fluorescent Immunoassay (FIA)
  • Detection of Total Anti-Infliximab Antibodies
  • Quantitative Detection of Total Anti-Infliximab Antibodies in Human Serum
  • 1.0 AU/mL
  • For In Vitro Diagnostic (IVD) Use Only
  • AFIAS Analyzer Series
  • Human Serum
  • Yes
  • Integrated on Cartridge
  • Within 15 Minutes
  • 25 Tests/Box
  • Single Use Cartridge
  • Pre-calibrated Cartridge
  • Therapeutic Drug Monitoring of Infliximab

Product Description

Brand                      Boditech

Sample Type           Serum/ Plasma

SMFP-74                  24T

CAT No                    SMFP-76

Biomarker               Therapeutic Drug Monitoring

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Total Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or plasma, and delivering results in 22 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.




Rapid and Reliable Testing

Gain results in under 15 minutes with Boditech AFIAS Total Anti-Infliximab, which combines high sensitivity (1.0 AU/mL) and specificity in a compact, disposable cartridge format. The integrated pre-calibration and barcode features make workflow effortless and minimize error potential, supporting efficiency in busy clinical environments.


Easy Integration and Usage

Compatible exclusively with the AFIAS Analyzer Series, this immunofluorescence cartridge requires no additional calibration. Simply load human serum samples into the cartridge, insert into the analyzer, and receive accurate, real-time results automatically. Lightweight and portable, it suits any clinical diagnostics setting.


Safe, Traceable, and Efficient

Each kit includes 25 single-use cartridges, ensuring hygienic operation and traceable lot information for quality assurance. All components are made from medical-grade plastic and reagents, and are supplied with clear storage instructions (2-8C) for optimum preservation and reliability throughout the 12-month shelf life.

FAQ's of Boditech AFIAS Total Anti-Infliximab:


Q: How is the Boditech AFIAS Total Anti-Infliximab test performed?

A: To perform the test, human serum is loaded into the disposable immunofluorescence cartridge, which is then inserted into any compatible AFIAS Analyzer Series device. The analyzer automatically processes the sample, with results available within 15 minutes.

Q: What does the AFIAS Total Anti-Infliximab kit measure?

A: This kit quantitatively detects total anti-infliximab antibodies in human serum samples, aiding in therapeutic drug monitoring for patients undergoing infliximab therapy.

Q: When should the test be used in clinical practice?

A: It is ideal for routine or on-demand monitoring of patients receiving infliximab. Use the kit whenever there is a clinical need to assess anti-infliximab antibody levels to optimize treatment efficacy.

Q: Where can the kit be utilized?

A: The kit is suitable for use in clinical laboratories, diagnostic centers, and hospital settings across India, provided an AFIAS Analyzer Series device is available.

Q: What is the benefit of a pre-calibrated cartridge and integrated barcode?

A: Pre-calibration eliminates the need for manual calibration, reducing setup complexity, while the integrated barcode ensures accurate lot tracking and data management for enhanced operational safety.

Q: How should the cartridges be stored for maximum shelf life?

A: Store all cartridges at 2-8C (refrigerated). Proper storage as per instructions helps maintain product efficacy for up to 12 months from the manufacturing date.

Q: Why choose this kit for therapeutic drug monitoring?

A: The kit provides rapid, accurate, and highly sensitive results with minimal operator input, supporting clinical decisions for infliximab therapy management. Its disposable, portable design and reliable performance make it a practical choice for modern healthcare teams.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical FIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.